acetaminophen has been researched along with Metabolic Syndrome in 5 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Despite abundant experimental data showing that fatty liver is more susceptible to liver injury, drug-induced liver disease seems no more frequent in NAFLD patients, except, possibly, a higher incidence but not severity of acetaminophen hepatotoxicity." | 4.90 | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. ( Pais, R; Ratziu, V; Rusu, E, 2014) |
| "Focal segmental glomerulosclerosis is a critical pathological lesion in metabolic syndrome-associated kidney disease that, if allowed to proceed unchecked, can lead to renal failure." | 1.42 | Acetaminophen attenuates glomerulosclerosis in obese Zucker rats via reactive oxygen species/p38MAPK signaling pathways. ( Arvapalli, R; Blough, E; Dai, X; Leidy, JW; Masannat, Y; Triest, WE; Wang, C; Wu, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 2 |
| Blough, ER | 1 |
| Arvapalli, R | 2 |
| Dai, X | 2 |
| Paturi, S | 1 |
| Manne, N | 1 |
| Addagarla, H | 1 |
| Triest, WE | 2 |
| Olajide, O | 1 |
| Wu, M | 2 |
| Pais, R | 1 |
| Rusu, E | 1 |
| Ratziu, V | 1 |
| Blough, E | 1 |
| Leidy, JW | 1 |
| Masannat, Y | 1 |
| Seki, E | 1 |
| Brenner, DA | 1 |
| Karin, M | 1 |
| Najman, DM | 1 |
| Kapoor, P | 1 |
| Serrano, A | 1 |
| Tckachenko, D | 1 |
2 reviews available for acetaminophen and Metabolic Syndrome
| Article | Year |
|---|---|
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.
Topics: Acetaminophen; Anesthetics; Animals; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; He | 2014 |
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Biomarkers; Carcinoma, Hepatocellular; Cell Death; | 2012 |
3 other studies available for acetaminophen and Metabolic Syndrome
| Article | Year |
|---|---|
Metabolic syndrome-induced tubulointerstitial injury: role of oxidative stress and preventive effects of acetaminophen.
Topics: Acetaminophen; Actins; Analgesics, Non-Narcotic; Animals; Apoptosis; bcl-2-Associated X Protein; Cas | 2013 |
Acetaminophen attenuates glomerulosclerosis in obese Zucker rats via reactive oxygen species/p38MAPK signaling pathways.
Topics: Acetaminophen; Animals; Chemokine CCL2; Connective Tissue Growth Factor; Fibronectins; Fibrosis; Gen | 2015 |
Hypertension and obesity.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Blood Pressure; Body Mass Index; | 2003 |